The efficacy of TGF-β1 inhibitor pirfenidone, free radical scavengers such as superoxide dismutase (SOD) and N-acetylcysteine, and NF-κB inhibitor SP100030 have been verified in experimental pulmonary fibrosis [14,15,16,17]. This evidence concerns the gene NFKB1 and pulmonary fibrosis.